Aspira Pathlab

Aspira Pathlab

61.93
+2.94
(4.98%)
Market Cap
63.73 Cr
EPS
1.97
PE Ratio
25.32
Dividend Yield
0.00 %
52 Week High
106.78
52 Week Low
39.61
PB Ratio
8.39
Debt to Equity
0.15
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
neutral
Five acquirers - Arvind Karsandas Bhanushali, Deepali Arvind Bhanushali, Jay Arvind Bhanushali, Nikunj Velji Mange, and Raj Arvind Bhanushali - along with Shraddha Nikunj Mange have announced an open offer to acquire 26,76,180 equity shares representing 26% of Aspira Pathlab & Diagnostics Limited's total paid-up equity shares. The offer price is set at Rs. 55 per share. The company disclosed this information on September 26, 2025, noting that the open offer follows SEBI takeover regulations.
positive
Aspira Pathlab Approves Q1 FY26 Results and Appoints Woman Independent DirectorAug 12, 2025
Aspira Pathlab & Diagnostics Limited approved its unaudited standalone and consolidated financial results for the quarter ended June 30, 2025. The company reported standalone revenue from operations of Rs 524.80 lakhs and profit after tax of Rs 46.94 lakhs. On a consolidated basis, revenue was Rs 524.80 lakhs with profit after tax of Rs 42.15 lakhs. The board appointed Dr. Alaka Keshav Deshpande as Additional Woman Independent Director for a three-year term from September 27, 2025 to September 26, 2028, subject to shareholder approval. The company also acquired the business undertaking of Aspira DNA Diagnostics Gujarat LLP for Rs 13.00 lakhs effective June 30, 2025.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
3,169.00
#1 26,548.46
52.17
#1 2,554.80
11.28
#1 492
24.30
48.34
2,040.00
10,567.58
68.52
1,346.30
10.64
146
18.90
43.26
1,021.70
10,491.54
69.35
699.70
23.06
144
22.54
46.31
1,104.20
5,851.65
55.86
702.20
20.80
91
60.25
39.98
790.80
2,553.47
31.98
742.70
16.70
78
14.53
44.10
299.25
1,558.52
46.65
255.90
15.11
31
19.48
48.47
1,354.95
1,162.93
23.87
111.60
28.72
48
11.50
40.60
318.70
1,013.80
#1 10.83
1,170.80
-18.47
-134
-35.12
57.31
275.45
538.28
20.39
147.80
#1 134.60
19
#1 444.44
59.70
185.35
129.13
88.74
41.80
13.28
2
0.00
42.17
Forecast
Actual
Growth Rate
Revenue Growth
64.71 %
Net Income Growth
-174.07 %
Cash Flow Change
74.29 %
ROE
-163.10 %
ROCE
-186.18 %
EBITDA Margin (Avg.)
-143.40 %

Quarterly Financial Results

Quarterly Financials
Jun 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
3
4
5
6
6
6
5
Expenses
3
4
4
5
5
5
5
EBITDA
-0
-0
0
1
1
1
1
Operating Profit %
-17 %
-5 %
6 %
21 %
11 %
16 %
13 %
Depreciation
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
Profit Before Tax
-1
-1
0
1
0
1
0
Tax
0
0
0
0
0
0
0
Net Profit
-1
-1
0
1
0
1
0
EPS in ₹
-0.70
-0.49
0.05
0.96
0.30
0.66
0.41

Balance Sheet

Balance Sheet
2024
2025
Total Assets
15
18
Fixed Assets
7
7
Current Assets
4
5
Capital Work in Progress
0
0
Investments
0
0
Other Assets
8
11
Total Liabilities
15
18
Current Liabilities
2
2
Non Current Liabilities
3
3
Total Equity
10
12
Reserve & Surplus
-5
-3
Share Capital
10
10

Cash Flow

Cash Flow
2024
2025
Net Cash Flow
0
1
Investing Activities
0
0
Operating Activities
1
2
Financing Activities
-1
-1

Share Holding

% Holding
Jan 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Aug 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
36.25 %
36.25 %
36.25 %
36.25 %
36.25 %
36.25 %
36.19 %
34.55 %
19.48 %
19.47 %
19.37 %
19.37 %
18.90 %
18.90 %
18.72 %
18.72 %
18.55 %
18.55 %
18.39 %
18.39 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
40.41 %
40.41 %
40.41 %
40.33 %
40.33 %
41.47 %
43.33 %
40.92 %
52.60 %
51.49 %
51.76 %
51.76 %
52.24 %
51.99 %
55.71 %
59.15 %
61.26 %
60.28 %
60.46 %
60.28 %
Others
23.34 %
23.34 %
23.34 %
23.42 %
23.42 %
22.28 %
20.48 %
24.54 %
27.91 %
29.04 %
28.87 %
28.87 %
28.86 %
29.11 %
25.57 %
22.13 %
20.19 %
21.18 %
21.15 %
21.33 %
No of Share Holders
536
535
535
710
852
868
955
1,141
1,300
1,300
1,371
1,371
1,406
1,351
1,512
1,695
1,706
1,593
1,741
1,770

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
16 Nov 2016 CHANGE OF NAME Change Of Name
NA
16 Nov 2016 0.00 0.00
27 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Sept 2024 32.42 41.39
12 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Nov 2024 50.14 61.75
07 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Feb 2025 77.00 70.07
16 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
16 May 2025 63.93 56.05
12 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Aug 2025 69.30 65.00
26 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
26 Sept 2025 63.00 61.87

Announcements

Announcement under Regulation 30 (LODR)-Cessation1 day ago
Announcement under Regulation 30 (LODR)-Public Announcement-Open Offer2 days ago
Announcement under Regulation 30 (LODR)-Change in Directorate2 days ago
Appointment Of Secretarial Auditor Of The Company2 days ago
Shareholder Meeting / Postal Ballot-Scrutinizers Report2 days ago
Public Announcement - Open Offer2 days ago
Shareholder Meeting / Postal Ballot-Outcome of AGM2 days ago
Closure of Trading Window3 days ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 05, 2025
Letters Dispatched To Non-Email ShareholdersSep 04, 2025
Notice Convening 52Nd Annual General Meeting To Be Held On Friday September 26 2025 At 02.00 P.M Through Video Conferencing Mode.Sep 04, 2025
Reg. 34 (1) Annual Report.Sep 04, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2025
Book Closure Record Date & E-Voting Intimation For The Purpose Of 52Nd Annual General Meeting.Aug 29, 2025
52Nd Annual General Meeting To Be Held On Friday September 26 2025 At 02.00 P.M (IST) Through Video Conferencing / Other Audio Visual Means.Aug 29, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 13, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateAug 12, 2025
Unaudited Standalone & Consolidated Financial Results For The Quarter Ended June 30 2025Aug 12, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On August 12 2025Aug 12, 2025
Board Meeting Intimation for Approval Of Un-Audited Financial Results (Standalone & Consolidated) For The First Quarter Ended On June 30 2025 And To Transact Other Businesses.Aug 02, 2025
Re-Appointment Of Dr. Pankaj J. Shah (DIN:02836324) As Managing Director & CEO For A Period Of Three (3) Years. Jul 10, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJul 10, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 08, 2025
Inauguration Of Three (3) New Diagnostics Centers In Gujarat.Jul 01, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionJul 01, 2025
Closure of Trading WindowJun 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 10, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotJun 09, 2025
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Jun 02, 2025
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015May 28, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 17, 2025
100% Acquisition Of Stake And Strike Off Of Aspira DNA Diagnostics Gujarat LLPMay 16, 2025
Re-Appointment Of Dr. Pankaj Shah (DIN: 02836324) As Managing Director & CEO Subject To The Members Approval For A Period Of Three (3) YearsMay 16, 2025
Intimation Of Appointment Of Secretarial Auditor And Internal AuditorMay 16, 2025
Integrated Filing (Financial)May 16, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Dated May 16 2025May 16, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Dated May 16 2025May 16, 2025
Board Meeting Intimation for Approval Of Audited Standalone & Consolidated Financial Results Of The Company Alongwith The Auditor Report As On March 31 2025May 07, 2025
Updation In Contact Details Of The Company Registrar And Share Transfer AgentApr 22, 2025
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2Apr 15, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 15, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2025
Intimation Under Regulation 30 Of The SEBI (LODR) Regulations 2015Apr 08, 2025
Closure of Trading WindowMar 26, 2025
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Mar 25, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 08, 2025
Integrated Filing (Financial)Feb 07, 2025
Board Meeting Outcome for For Unaudited Financial Results (Both Standalone & Consolidated) Alongwith Limited Review Report For The Quarter And Nine Months Ended December 31 2024 And Other Businesses TFeb 07, 2025
Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024Jan 31, 2025

Technical Indicators

RSI(14)
Neutral
38.41
ATR(14)
Volatile
2.86
STOCH(9,6)
Neutral
35.47
STOCH RSI(14)
Oversold
7.10
MACD(12,26)
Bearish
-0.55
ADX(14)
Weak Trend
10.89
UO(9)
Bearish
38.98
ROC(12)
Downtrend And Accelerating
-9.06
WillR(14)
Oversold
-97.51